Oncopeptides competitive analysis

Latest publications and patents of Oncopeptides New

Explore the latest publications and patents granted to Oncopeptides, showcasing their recent innovations and technological advancements.

Last updated on: Sep 24, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Oncopeptides

Sep 6, 2023Melflufen Dosage Regimens For CancerPatent Maintained As Amended

Explore patent oppositions filed by Oncopeptides against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 25, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Liquid Pharmaceutical FormulationPROJECT PHARMACEUTICSMar 22, 2023

Explore Oncopeptides's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 25, 2025
Patent NumberGrant DateTitleTotal Oppositions
Sep 6, 2023Melflufen Dosage Regimens For Cancer2

Latest PTAB cases involving Oncopeptides

Discover the latest PTAB cases involving Oncopeptides, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Oncopeptides with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 25, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
ONCOPEPTIDES12 - - Balanced
LUIGI16 - - - Highly Aggressive
PROJECT PHARMACEUTICS - 2 - - Non-Active
SYNTHON3216 - - Highly Aggressive